Aptevo Therapeutics Inc. announced its decision to conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20. This action is aimed at increasing the per-share trading price of its common stock to meet Nasdaq's minimum bid price requirement.
The Reverse Stock Split is expected to become effective on May 23, 2025, at 5:01 p.m. Pacific Time. This corporate adjustment will reduce the number of shares outstanding while proportionally increasing the stock price, without altering the aggregate value of shareholders' equity.
This measure is part of Aptevo's broader Nasdaq compliance plan, demonstrating the company's commitment to maintaining its listing status. The reverse stock split is a necessary step to ensure continued eligibility for trading on the Nasdaq Capital Market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.